2025-01-23
On January 14th, San Francisco time, the “YAFO East-Meets-West Reception” hosted by YAFO Capital and co-organized by Ideals Virtual Data Room concluded successfully at JPM. The dinner gathered industry leaders, business executives, and experts in the pharmaceutical and biotechnology fields to discuss the future development direction of innovative medical drugs.
At the beginning of the event, Victor Ye, Managing Partner of YAFO Capital, delivered the opening speech, kicking off the dinner.
Subsequently, Mr. Peng Luo, Business Development Manager of Ideals Virtual Data Room, on behalf of Mr. John Yuan, Global Vice President & Head of the East Asia Region, conducted the lucky draw, elevating the atmosphere to a climax.
Mr. Kun Tao, Head of YAFO’s US Business Department (left), presented the lucky prize to Ms. Ling Tong (center), filling the venue with joy and excitement.
In an atmosphere full of interaction and inspiration, the attending guests deeply exchanged ideas on emerging trends and opportunities in the global pharmaceutical field. Through the collision of ideas and the sharing of experiences, they paved the way for future development. Additionally, the dinner provided a platform for communication and cooperation, aiding in the establishment of new partnerships and advancing the process of global pharmaceutical innovation.
Finally, the YAFO team took a group photo, marking the successful conclusion of the dinner.
We sincerely thank all the guests for their participation and contributions; it is your support that made this event a success!
Here are our upcoming events:
April 2025: ACCESS CHINA Spring Roadshow (online)
June 2025: ACCESS CHINA Partnering Forum @BIO (online & Boston)
We eagerly look forward to your participation. Let us work together to drive global pharmaceutical innovation!
About YAFO Capital
关于雅法资本
Founded in 2013, YAFO Capital is a Shanghai-based boutique investment and advisory firm, with a professional team in our China, U.S., EU, and SEA offices. Partnering with Pharmaceutical companies, YAFO Fund mainly invests in global assets. YAFO Life Sciences is a leading advisory boutique focused on asset transactions. YAFO has built a strong proven track record and closed dozens of in-licensing and out-licensing transactions with global pharma and biotech companies. Over the past five years, YAFO has been ranked as the No. 1 advisor for China cross-border licensing transactions. For more information, please visit www.yafocapital.com
雅法资本成立于2013年，作为新型投资和投行咨询机构，致力于中国及海外生物医药项目的投融资、资产跨境交易和资产孵化等。旗下雅法基金联合药企进行资产投资和并购，雅法全球医疗专注于医药产品跨境及国内授权交易。基于雅法在全球广泛的人脉与资源网络，在过去十年成功推进了大量的海外项目进入中国市场并协助多个中国产品完成海外授权。雅法拥有经验丰富的全球交易团队，覆盖美国、日本 、欧洲等全球主要医药创新区域。核心合伙人均为华尔街资深投行人士或具有跨国药企经历，为客户交易提供强力支持。雅法总部位于上海，在美国、欧洲、东南亚等地均设有分部。雅法在生物医药跨境授权及并购业务交易数量连续多年排名第一。
更多信息请访问https://www.yafocapital.com/
Contact us
Wendi Xiang, Vice President
YAFO Capital (Shanghai) 雅法资本
Email: wxiang@yafocapital.com
BioToChina.org 